SREBF1 Gene
Introduction
Srebf1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<nav class="infobox .infobox-gene">
| SREBF1 Gene | |
|---|---|
| Full Name | Sterol Regulatory Element Binding Transcription Factor 1 |
| Symbol | SREBF1 (SREBP1) |
| Chromosome | 17p11.2 |
| NCBI Gene ID | 6720 |
| OMIM | 184756 |
| Ensembl ID | ENSG00000172318 |
| UniProt | P36956 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Metabolic Syndrome, Fatty Liver Disease, Huntington's Disease, ALS |
</nav>
Overview
The SREBF1 gene (commonly known as SREBP1) encodes sterol regulatory element-binding protein 1, a critical transcription factor that regulates lipid metabolism and cellular energy homeostasis[@horton2002]. SREBP1 serves as the master regulator of fatty acid and triglyceride synthesis, controlling genes involved in lipogenesis, cholesterol biosynthesis, and lipid droplet formation. Beyond its well-established role in metabolic diseases, SREBP1 has emerged as an important player in neurodegenerative disorders, where lipid dysregulation contributes to disease pathogenesis[@brown2018].
SREBP1 belongs to the SREBP family of transcription factors:
...SREBF1 Gene
Introduction
Srebf1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<nav class="infobox .infobox-gene">
| SREBF1 Gene | |
|---|---|
| Full Name | Sterol Regulatory Element Binding Transcription Factor 1 |
| Symbol | SREBF1 (SREBP1) |
| Chromosome | 17p11.2 |
| NCBI Gene ID | 6720 |
| OMIM | 184756 |
| Ensembl ID | ENSG00000172318 |
| UniProt | P36956 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Metabolic Syndrome, Fatty Liver Disease, Huntington's Disease, ALS |
</nav>
Overview
The SREBF1 gene (commonly known as SREBP1) encodes sterol regulatory element-binding protein 1, a critical transcription factor that regulates lipid metabolism and cellular energy homeostasis[@horton2002]. SREBP1 serves as the master regulator of fatty acid and triglyceride synthesis, controlling genes involved in lipogenesis, cholesterol biosynthesis, and lipid droplet formation. Beyond its well-established role in metabolic diseases, SREBP1 has emerged as an important player in neurodegenerative disorders, where lipid dysregulation contributes to disease pathogenesis[@brown2018].
SREBP1 belongs to the SREBP family of transcription factors:
| Isoform | Gene | Function | Tissue Expression |
|---------|------|----------|-------------------|
| SREBP1a | SREBF1 | Strong activator, full-length | Widely expressed |
| SREBP1c | SREBF1 | Insulin-regulated isoform | Liver, adipose, brain |
The SREBP1 gene produces multiple transcripts through alternative splicing:
- SREBP1a: More potent transcription factor, wider target gene range
- SREBP1c: Primarily regulates fatty acid synthesis, insulin-responsive
Protein Structure
SREBP1 contains several functional domains:
- N-terminal transcription activation domain - Transactivates target genes
- Sterol-sensing domain - Responds to sterol levels
- Basic-helix-loop-helix-leucine zipper (bHLH-LZ) - DNA binding
- C-terminal regulatory domain - Interactions with SCAP and INSIG
Molecular Function
SREBP1 controls the expression of genes involved in[@shimano2017]:
Fatty Acid Synthesis:
- ACC (Acetyl-CoA carboxylase)
- FAS (Fatty acid synthase)
- SCD1 (Stearoyl-CoA desaturase)
Triglyceride Synthesis:
- GPAT (Glycerol-3-phosphate acyltransferase)
- DGAT (Diacylglycerol acyltransferase)
Cholesterol Synthesis:
- HMG-CoA reductase (rate-limiting)
- HMG-CoA synthase
- Squalene synthase
Cellular Processes
Beyond lipid synthesis, SREBP1 regulates:
ER stress response - Links lipid metabolism to [unfolded protein response](/entities/unfolded-protein-response)
[Autophagy](/entities/autophagy) - Modulates lipid droplet catabolism
Inflammation - [NF-κB](/entities/nf-kb) signaling modulation
Cell growth - Coordinates lipid availability with proliferationRegulation
Transcriptional Regulation
- Insulin signaling: PI3K/Akt pathway activates SREBP1c
- Glucose: ChREBP cooperation
- Leptin: Negative regulation
- Glucocorticoids: Activation
Post-translational Regulation
- Proteolytic cleavage: SCAP-mediated ER to Golgi trafficking
- Sterol feedback: Cholesterol levels control maturation
- Phosphorylation: [mTOR](/entities/mtor) and AMPK modify activity
- Ubiquitination: Protein stability control
Expression Pattern
Brain Regional Distribution
SREBP1 is expressed throughout the brain:
- Cerebral [cortex](/brain-regions/cortex) - High neuronal expression
- [Hippocampus](/brain-regions/hippocampus) - CA regions, dentate gyrus
- Cerebellum - Purkinje cells
- Hypothalamus - Metabolic regulation
- Substantia nigra - Dopaminergic neurons
- Striatum - Medium spiny neurons
Cell Type Specificity
- [Neurons](/entities/neurons): Moderate expression, activity-dependent
- [Astrocytes](/entities/astrocytes): High expression for lipid provision
- Oligodendrocytes: Myelin lipid synthesis
- [Microglia](/entities/microglia): Modulated by inflammation
Disease Associations
Alzheimer's Disease (AD)
SREBP1 dysregulation is prominent in AD[@liu2022]:
Lipid Metabolism Abnormalities:
- Altered brain cholesterol homeostasis
- Changed fatty acid composition
- Lipid droplet accumulation in glia
Amyloid Processing:
- SREBP1 affects [APP](/entities/app-protein) processing
- Altered [γ-secretase](/entities/gamma-secretase) activity
- [Aβ](/proteins/amyloid-beta)-induced lipotoxicity
Therapeutic Implications:
- SREBP1 modulators under investigation
- Diet interventions affect SREBP1
- Statins have indirect effects
Parkinson's Disease (PD)
SREBP1 involvement in PD[@van2019]:
- [α-Synuclein](/proteins/alpha-synuclein) interaction: Lipid environments affect aggregation
- Mitochondrial function: Lipid composition affects respiration
- Neuroinflammation: SREBP1 modulates glial activation
- Dopaminergic vulnerability: Lipid homeostasis critical
Huntington's Disease (HD)
SREBP1 dysfunction in HD:
- Transcriptional dysregulation: Mutant [huntingtin](/proteins/huntingtin-protein) affects SREBP1
- Metabolic abnormalities: Lipid metabolism altered
- Therapeutic target: SREBP1 modulation may help
Amyotrophic Lateral Sclerosis (ALS)
- Lipid metabolism in motor neurons
- Energy homeostasis disruption
- Lipid droplet accumulation
SREBP1 hyperactivity contributes to:
- Obesity: Increased lipogenesis
- Fatty liver: Hepatic lipid accumulation
- Insulin resistance: Lipid intermediates interfere with signaling
- Dyslipidemia: Elevated triglycerides
Therapeutic Implications
Pharmacological Approaches
| Approach | Compound | Mechanism | Status |
|----------|----------|-----------|--------|
| SREBP1 inhibitor | Fatostatin | Prevents cleavage | Preclinical |
| SREBP1 inhibitor | Betulin | Blocks maturation | Preclinical |
| Statins | Simvastatin | Indirect reduction | Approved |
| Farnesoid X receptor agonists | Obeticholic acid | FXR-SREBP1 axis | Approved for PBC |
Lifestyle Interventions
- Calorie restriction: Reduces SREBP1 activity
- Ketogenic diet: Alternative energy substrate
- Exercise: Improves insulin sensitivity
- Omega-3 fatty acids: Counteracts dyslipidemia
Emerging Therapies
- Gene therapy: Targeted delivery
- Antisense oligonucleotides: SREBP1 knockdown
- CRISPR editing: Epigenetic modulation
Research Techniques
Experimental Methods
- ChIP-seq: Genome-wide binding analysis
- RNA-seq: Transcriptomic profiling
- Lipidomics: Comprehensive lipid analysis
- Proteomics: Protein interaction studies
- Metabolomics: Metabolic pathway analysis
Animal Models
- SREBP1 knockout: Embryonic lethal (SREBP1a), viable (SREBP1c)
- Conditional knockouts: Tissue-specific deletion
- Transgenic overexpression: Lipid accumulation models
See Also
- [Lipid Metabolism Pathway](/mechanisms/lipid-metabolism-dysregulation)
- [Metabolic Dysfunction Pathway](/mechanisms/metabolic-dysfunction-pathway)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Huntington's Disease](/diseases/huntington-disease)
- [Cholesterol Metabolism](/mechanisms/cholesterol-metabolism)
- [SCD1 Gene](/proteins/scd1-protein)
- [FASN Gene](/proteins/fasn-protein)
External Links
- [NCBI Gene: SREBF1](https://www.ncbi.nlm.nih.gov/gene/6720)
- [UniProt: P36956](https://www.uniprot.org/uniprot/P36956)
- [HGNC: SREBF1](https://www.genenames.org/data/hgnc_data.php?hgnc_id=11289)
- [OMIM: 184756](https://www.omim.org/entry/184756)
Background
The study of Srebf1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Horton JD, Goldstein JL, Brown MS, SREBPs: transcriptional activators of the complete program of cholesterol and fatty acid synthesis in the liver (2002)](https://doi.org/10.1172/JCI15593)
[Brown MS, Radhakrishnan A, Goldstein JL, Retrospective on Cholesterol Homeostasis: The Central Role of SREBP (2018)](https://doi.org/10.1101/cshperspect.a033290)
[Shimano H, Sato R, SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology (2017)](https://doi.org/10.1038/nrendo.2017.91)
[Liu Y, Chen L, Gong J, SREBP1 in Alzheimer's Disease: A Potential Therapeutic Target (2022)](https://doi.org/10.3389/fnagi.2022.856785)
[Van der Burg JM, Bjorkqvist M, Brundin P, Beyond the brain: widespread pathology in Huntington's disease (2019)](https://doi.org/10.1016/S1474-4422(19)Pathway Diagram
Mermaid diagram (expand to render)
Pathway Diagram
The following diagram shows the key molecular relationships involving SREBF1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)